SCHEMBL3328301

SCHEMBL3328301

CC(C)NC(C)C.CC(C)NC(C)C.[MgH2]

nearest known ligand 0.89

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.89

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7746404 1.00
Bromide SCHEMBL6924630 0.95 TDP1 (0.80) TDP1
Lithium SCHEMBL9301207 0.95 TDP1 (0.80) TDP1
SCHEMBL27928984 0.94 TDP1 (1.00) TDP1
SCHEMBL1332279 0.94
SCHEMBL2020 0.94
Hydrochloric Acid SCHEMBL23748751 0.91 TDP1 (0.73) TDP1
Hydrochloric Acid SCHEMBL28849153 0.91 TDP1 (0.73) TDP1
Hydrochloric Acid SCHEMBL28377416 0.91 TDP1 (0.73) TDP1
SCHEMBL4800423 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107847921-B Hydrosilylation reaction catalyst 国立大学法人九州大学 2022-01-14 CN disclosed
US-8304531-B2 Process for the preparation of an (RP)-8-substituted cAMPS SOLVELL AS (NO) 2012-11-06 US disclosed
US-20100137237-A1 PROCESS FOR THE PREPARATION OF AN (RP)-8-SUBSTITUTED CAMPS LAURAS AS (NO) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137237-A1 PROCESS FOR THE PREPARATION OF AN (RP)-8-SUBSTITUTED CAMPS AMPD3, ATIC, PDE8A TDP1 1481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.